FDA Recall: Ranitidine Products
Subscribe
FDA Recall: Ranitidine Products
FDA Recall: Ranitidine Products
Please be advised, The FDA has ordered a recall of all Ranitidine products, due to manufacturing issues.
Patients taking any form of prescription Ranitidine (tablets or liquids) have been asked to discontinue and contact their doctor for an alternative.
Persons have also been advised not to purchase over-the-counter Ranitidine products (e.g. Zantac®).
Comments (0)
We appreciate your feedback. You can comment here with your pseudonym or real name. You can leave a comment with or without entering an email address. All comments will be reviewed before they are published.